THE UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER appointed a four-member leadership team to oversee the center’s research operations. The appointments became effective Sept. 15.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
